Farallon Capital Management LLC Revolution Medicines, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 11,317,692 shares of RVMD stock, worth $490 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares

11,317,692

Previous 9,757,692 15.99%

Holding current value

$490 Million

Previous $379 Million 35.41%

% of portfolio

2.58%

Previous 1.83%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $57.6 Million - $74.8 Million	1,560,000 Added 15.99%	11,317,692 $513 Million
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $67.8 Million - $91.5 Million	2,249,820 Added 29.97%	9,757,692 $379 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $20.5 Million - $25.9 Million	771,018 Added 11.44%	7,507,872 $242 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $124 Million - $230 Million	6,736,854 New	6,736,854 $193 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $83.7 Million - $117 Million	3,325,480 New	3,325,480 $92 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $10.1 Million - $13.5 Million	-500,120 Reduced 15.23%	2,783,480 $74.5 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $32.9 Million - $47.7 Million	1,585,585 Added 93.38%	3,283,600 $71.1 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $14.2 Million - $20.5 Million	-801,985 Reduced 32.08%	1,698,015 $40.4 Million
Q3 2022 Nov 14, 2022	SELL	$17.46 - $26.0 $13.1 Million - $19.5 Million	-750,000 Reduced 23.08%	2,500,000 $49.3 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $8.66 Million - $13.2 Million	500,000 Added 18.18%	3,250,000 $82.9 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $5.99 Million - $8.35 Million	250,000 Added 10.0%	2,750,000 $75.7 Million
Q2 2021 Aug 13, 2021	BUY	$29.0 - $47.44 $25.8 Million - $42.2 Million	890,270 Added 55.31%	2,500,000 $79.4 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $59.1 Million - $86.5 Million	1,588,997 Added 7664.1%	1,609,730 $73.9 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $414,660 - $706,580	20,733 New	20,733 $454,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Revolution Medicines, Inc. Transaction History